Streptococcus pneumoniae's Virulence and Host Immunity: Aging, Diagnostics, and Prevention
LRK Brooks, GI Mias - Frontiers in immunology, 2018 - frontiersin.org
Streptococcus pneumoniae is an infectious pathogen responsible for millions of deaths
worldwide. Diseases caused by this bacterium are classified as pneumococcal diseases …
worldwide. Diseases caused by this bacterium are classified as pneumococcal diseases …
Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre-and post-conjugate vaccine eras: a United States perspective
L Kim, L McGee, S Tomczyk, B Beall - Clinical microbiology …, 2016 - Am Soc Microbiol
Streptococcus pneumoniae inflicts a huge disease burden as the leading cause of
community-acquired pneumonia and meningitis. Soon after mainstream antibiotic usage …
community-acquired pneumonia and meningitis. Soon after mainstream antibiotic usage …
The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious …
GP Wormser, RJ Dattwyler, ED Shapiro… - Clinical Infectious …, 2006 - academic.oup.com
Evidence-based guidelines for the management of patients with Lyme disease, human
granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and …
granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and …
Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention
MS Niederman, LA Mandell, A Anzueto… - American journal of …, 2001 - atsjournals.org
This document is an update of the original 1993 statement on community-acquired
pneumonia, incorporating new information about bacteriology, patient stratification …
pneumonia, incorporating new information about bacteriology, patient stratification …
Standards of medical care in diabetes
American Diabetes Association - Diabetes care, 2005 - search.proquest.com
Abstract The American Diabetes Association standards of medical care in diabetes are
presented. They are intended to provide clinicians, patients, researchers, payors, and other …
presented. They are intended to provide clinicians, patients, researchers, payors, and other …
Rates of pneumococcal disease in adults with chronic medical conditions
KM Shea, J Edelsberg, D Weycker… - Open forum …, 2014 - academic.oup.com
Background. Although it is widely accepted that adults with immunocompromising conditions
are at greatly increased risk of pneumococcal infection, the extent of risk among …
are at greatly increased risk of pneumococcal infection, the extent of risk among …
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
Objective To assess the effects of the B lymphocyte stimulator (BLyS)–specific inhibitor
belimumab on immunologic biomarkers, including B cell and T cell populations, and …
belimumab on immunologic biomarkers, including B cell and T cell populations, and …
Practice guidelines for the management of community-acquired pneumonia in adults
JG Bartlett, SF Dowell, LA Mandell… - Clinical infectious …, 2000 - academic.oup.com
Guidelines for the management of community-acquired pneumonia were issued on behalf of
the Infectious Diseases Society of America in April 1998. The present version represents a …
the Infectious Diseases Society of America in April 1998. The present version represents a …
Standards of medical care for patients with diabetes mellitus
American Diabetes Association - Diabetes care, 2003 - Am Diabetes Assoc
Diabetes is a chronic illness that re-quires continuing medical care and patient self-
management education to prevent acute complications and to reduce the risk of long-term …
management education to prevent acute complications and to reduce the risk of long-term …
Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial
Objective To examine immunization responses in patients with rheumatoid arthritis (RA)
treated with rituximab and to investigate the effects of rituximab‐induced CD20+ B cell …
treated with rituximab and to investigate the effects of rituximab‐induced CD20+ B cell …